ProxyMiner / Company

BIO-RAD LABORATORIES, INC.BIO

Latest proxy: 2026 · view on SEC ↗ · CIK 0000012208

↓ Export PDF

← All companies

CEO total pay

$7,995,841

Norman Schwartz · 2025

Say on pay

Not disclosed

Use Ask for the underlying narrative

CEO pay ratio

Item 402(u)

97 to 1

Median employee: $82,784

Compensation committee

CD&A

Compensation Committee

Per the latest proxy

Filings indexed: 2 · 2026 · 2025

Executive pay

What did they pay them?

From the Summary Compensation Table. Pay mix and YoY are computed from these rows.

Executive	Role	TotalYoY	Pay mix	Salary	Stock	Cash incentive	Other
Norman Schwartz2025 compensation	Chief Executive Officer and Chairman	$7,995,841↓ 4%	86% at-risk	$1,089,877	$4,856,574	$562,088	$28,327
Roop K. Lakkaraju2025 compensation	Executive Vice President, Chief Financial Officer	$2,990,738↓ 21%	78% at-risk	$629,100	$1,618,956	$334,212	$21,112
Jonathan P. DiVincenzo2025 compensation	President and Chief Operating Officer	$3,680,772↓ 15%	81% at-risk	$673,208	$2,023,696	$476,702	$23,044
Rajat Mehta2025 compensation	Executive Vice President, Global Commercial Operations	$2,680,042	91% at-risk	$220,096	$2,158,707	$270,106	$31,133
James Barry2025 compensation	Executive Vice President, President, Life Science Group	$2,611,227	68% at-risk	$536,752	$1,214,217	$266,079	$303,685

Pay mix: base cash incentive equity other

Add to peer comparison →Year-over-year diff →

CD&A excerpt

Compensation discussion & analysis

Opening passage of the loaded filing's CD&A. Use Ask below to query the full text with citations.

In this Compensation Discussion and Analysis, we review the objectives and elements of our execution compensation program and discuss the 2025 compensation earned by our named executive officers, or NEOs. For 2025, our named executive officers were: NamePositionNorman Schwartz Chief Executive Officer and Chairman of the Board Roop K. Lakkaraju Executive Vice President, Chief Financial Officer Jonathan P. DiVincenzo President and Chief Operating Officer Rajat MehtaExecutive Vice President, Global Commercial Operations James BarryExecutive Vice President and President, Life Science Group COMPENSATION PROGRAM OBJECTIVES AND PHILOSOPHY We maintain various compensation programs for our named executive officers. Our executive compensation program, taken as a whole, has several objectives. The overriding objective of our executive compensation program is to attract, retain, motivate and develop the type of executives who will establish and execute strategic initiatives that help us to continue to grow a profitable business. We also want our executive compensation program to help align the interests of the executives with the interests of the Company and its stockholders. Finally, we want …

Read the full CD&A on SEC.gov ↗

Peer comparison

Who they benchmark against

Click any peer to jump to their proxy. Peers we haven't ingested yet kick off an import on click.

Governance

Policy guardrails

hedging
prohibited
“Our Insider Trading Compliance Policy trading policy prohibits our officers, directors, employees and consultants from engaging in (i) hedging transactions or similar arrangements that have the effect of offsetting any d…”
clawback
present
“clawback policy in compliance with NYSE listing standards and Section 10D of the Exchange Act effective October 2, 2023”
stock ownership guidelines
present
“stock ownership guidelines for senior executives at the executive vice president level and above, including our named executive officers”
change in control
in control benefits in the event of a qualifying termination of employment with us that are as described more fully under “Potential Payments on Termination or Change in Control.”
“in control benefits in the event of a qualifying termination of employment with us that are as described more fully under “Potential Payments on Termination or Change in Control.””
compensation committee
Compensation Committee
“acted as a compensation advisor to our Compensation Committee”

Performance markers

Metric facts

revenue
$17
“in Control.” 401(k) Plan The Company offers to all regular status employees the opportunity to participate in a 401(k) Profit Sharing Plan. The 401(k) Profit Sharing Plan permits eligible employees of the Company to defe…”
operating income
$355.0
“our financial goals under the IBP for fiscal 2025 relevant to our named executive officers for Corporate goals, and our performance compared to those goals (in millions): IBPTarget PlanAdjusted IBPTarget Plan(1)ActualAdj…”
ceo pay ratio
97 to 1
“to Item 402(u) of Regulation S-K, we are providing the following reasonable estimate of the ratio of the median annual total compensation of all of our employees and the annual total compensation of our CEO, Norman Schwa…”
median employee compensation
$82,784
“PAY RATIO DISCLOSURE Pursuant to Item 402(u) of Regulation S-K, we are providing the following reasonable estimate of the ratio of the median annual total compensation of all of our employees and the annual total compens…”

Ask

Anything about BIO-RAD LABORATORIES, INC.’s 2026 proxy

Answers are grounded in the loaded filing and cite specific artifacts. Bring your own free Google AI Studio key.

Loading the Ask interface…